Patent ID: 9457005
Filing Date: 2016-10-04
CPC Classification: A61K,A61P

Claim Text:
1. A method of treating insulin resistance, comprising: identifying a subject having a blood-glucose condition characterized by insulin resistance in need of treatment, wherein the condition is Type 2 diabetes and the subject is treated with insulin; and administering to the subject an amount of a composition that is effective to treat the insulin resistance, wherein the composition comprises naltrexone or a pharmaceutically acceptable salt thereof and bupropion or a pharmaceutically acceptable salt thereof, wherein the amount of the naltrexone or pharmaceutically acceptable salt thereof is about 25 mg per day to about 50 mg per day, and wherein the amount of the bupropion or pharmaceutically acceptable salt thereof is about 200 mg per day to about 400 mg per day; obtaining a measurement of the subject's blood glucose level following treatment with said composition; and decreasing the amount of insulin used in the insulin treatment in response to the measurement of the subject's blood glucose level following treatment with said composition.